Search Results for "Pharma New Product Launch India"

15:49 EDT 28th April 2017 | BioPortfolio

Matching Channels

India ink colloidal carbon stain


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...


Eligard® is a hormone compound for the treatment of advanced, hormone-dependent prostate cancer. The active ingredient (leuprolide acetate) significantly reduces the level of the male sex hormon...

Datamonitor - aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapidly evolving marketplace

The Datamonitor Group aims to help its clients operating in the pharmaceuticals, healthcare and biotechnology fields, offering world-leading products and services to meet the challenges of this rapi...


Labs are the hub of much of modern medicine, either in the hospital setting processing patients blood tests and other samples, in research institutions at many universities or in the headquarters of...

Matching News

International executives forecast 24% growth in India for 2017, and remarkably, 96% agreed that CDSCO certification programmes are helping increase compliance

CPhI & P-MEC India 2016 – organised by UBM EMEA and UBM India – announce the international survey data from its in-depth research on pharma in India following the closing of the first CPhI Indi...

India’s ‘Cautious’ View Dulls Sanofi Hopes For Early Dengvaxia Launch

An early rollout of Sanofi Pasteur’s dengue vaccine in India is looking less likely with a senior functionary of the...  

India's Sun Pharma Buys Novartis Oncology Drug

The transaction marks Sun Pharma's first branded oncology product, Odomzo, for global markets

Alvogen, Natco launch first Tamiflu generic

David Salazar PINE BROOK, N.J.and HYDERABAD, India — Alvogen and Natco Pharma on Monday announced the launch of their generic of Tamiflu (oseltamivir phosphate) capsules, the first generic of t...

India Drug Watchdog Says 4-5% Of Drugs Still Substandard

Health authorities have been working for years toward ensuring the safety of medicines in the global supply chain, and India...    

India’s Trial Approval Timelines Report Card – Some Red Lines?

India’s streamlined clinical trial approvals process appears to have made some gains, but top industry experts tell Pink Sheet how...   

India Pharma 2017 to be held in Bengaluru from February 11 to13, 2017

The Department of Pharmaceuticals, in association with the Federation of Indian Chambers of Commerce & Industry (FICCI) will be holding the India Pharma 2017 ─ second international exhibition and co...

Sun Pharma inaugurates first Egypt production facility

Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further cement India/Middle East business relations for the holding company. read more

Matching PubMed Articles

The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.

In the context of increased pharmaceutical innovation deficits and Big Pharma blockbusters' patent expirations, this paper examines the moderating role of firms' absorptive capacity in external innova...

Tropospheric ozone pollution in India: effects on crop yield and product quality.

Ozone (O3) in troposphere is the most critical secondary air pollutant, and being phytotoxic causes substantial losses to agricultural productivity. Its increasing concentration in India particularly ...

Case series of cochicium autumnale plant product poisoning.

Eclampsia in India Through the Decades.

Eclampsia is still prevalent in India with high maternal and perinatal mortality. In India, there is no community-based survey of eclampsia. Sporadic reports of study on eclampsia are being published ...

Is tobacco use increasing among medical students of Bengaluru city, India? Evidence from two cross-sectional studies.

Studies investigating secular changes in tobacco use are rare in India. We estimated self-reported prevalence of tobacco use, across a 5-year interval, among medical students in Bengaluru, India.

Search Whole site using Google

Quick Search
Advertisement Advertisement